Published in BMJ Open on January 15, 2014
Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's Haematological Malignancy Research Network. Br J Cancer (2015) 1.04
Impact of age and socioeconomic status on treatment and survival from aggressive lymphoma: a UK population-based study of diffuse large B-cell lymphoma. Cancer Epidemiol (2015) 0.85
Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK's population-based Haematological Malignancy Research Network 2004-15. Cancer Epidemiol (2016) 0.84
Improved survival boosts the prevalence of chronic myeloid leukemia: predictions from a population-based study. J Cancer Res Clin Oncol (2016) 0.76
Low educational level but not low income impairs the achievement of cytogenetic remission in chronic myeloid leukemia patients treated with imatinib in Brazil. Clinics (Sao Paulo) (2015) 0.75
Estimating the prevalence of hematological malignancies and precursor conditions using data from Haematological Malignancy Research Network (HMRN). Cancer Causes Control (2016) 0.75
The role of observational studies in optimizing the clinical management of chronic myeloid leukemia. Ther Adv Hematol (2015) 0.75
A Multi-centric Bioequivalence Trial in Ph+ Chronic Myeloid Leukemia Patients to Assess Bioequivalence and Safety Evaluation of Generic Imatinib Mesylate 400 mg Tablets. Cancer Res Treat (2016) 0.75
Chronic myeloid leukemia incidence, survival and accessibility of tyrosine kinase inhibitors: a report from population-based Lithuanian haematological disease registry 2000-2013. BMC Cancer (2016) 0.75
Emergency admission and survival from aggressive non-Hodgkin lymphoma: A report from the UK's population-based Haematological Malignancy Research Network. Eur J Cancer (2017) 0.75
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med (2006) 22.86
Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia. Leukemia (2009) 6.29
Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib. J Clin Oncol (2010) 4.21
Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study. Blood (2009) 3.47
Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network. Br J Cancer (2011) 2.69
Generalizability of cancer clinical trial results: prognostic differences between participants and nonparticipants. Cancer (2006) 2.30
Variation in incidence of breast, lung and cervical cancer and malignant melanoma of skin by socioeconomic group in England. BMC Cancer (2008) 1.89
Chronic myeloid leukemia in Asia. Int J Hematol (2008) 1.86
Chronic myeloid leukemia: 2012 update on diagnosis, monitoring, and management. Am J Hematol (2012) 1.77
The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research. Br J Haematol (2009) 1.67
A population study of imatinib in chronic myeloid leukaemia demonstrates lower efficacy than in clinical trials. Leukemia (2008) 1.64
Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia. Blood (2012) 1.64
Cost-effectiveness of dasatinib and nilotinib for imatinib-resistant or -intolerant chronic phase chronic myeloid leukemia. Value Health (2011) 1.48
Incidence, survival and prevalence of myeloid malignancies in Europe. Eur J Cancer (2012) 1.32
Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry. Blood (2013) 1.27
Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party. Blood (2011) 1.19
Current issues in chronic myeloid leukemia: monitoring, resistance, and functional cure. J Natl Compr Canc Netw (2012) 1.17
Epidemiology of chronic myeloid leukaemia (CML). Best Pract Res Clin Haematol (2009) 1.14
Nonadherence to imatinib adversely affects event free survival in chronic phase chronic myeloid leukemia. Am J Hematol (2011) 1.12
Cancer survival disparities by health insurance status. Cancer Med (2013) 1.10
Does increasing insurance improve outcomes for US cancer patients? J Surg Res (2013) 1.05
Trends in chronic myeloid leukemia incidence and survival in the United States from 1975 to 2009. Leuk Lymphoma (2012) 1.00
Chronic myeloid leukemia: overview of new agents and comparative analysis. Curr Treat Options Oncol (2013) 0.98
Survival of patients with chronic myelocytic leukemia: comparisons of estimates from clinical trial settings and population-based cancer registries. Oncologist (2011) 0.98
Population level survival of patients with chronic myelocytic leukemia in Germany compared to the US in the early 21st century. J Hematol Oncol (2013) 0.96
Imatinib as the first-line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: can we compare real life data to the results from clinical trials? Am J Hematol (2011) 0.88
Long-term safety and efficacy of imatinib mesylate (Gleevec®) in elderly patients with chronic phase chronic myelogenous leukemia: results of the AFR04 study. Am J Hematol (2012) 0.86
Disparities and challenges in adherence to oral antineoplastic agents. Am Soc Clin Oncol Educ Book (2013) 0.82
Quantification of imatinib in human serum: validation of a high-performance liquid chromatography-mass spectrometry method for therapeutic drug monitoring and pharmacokinetic assays. Drug Des Devel Ther (2013) 0.81
What challenges remain in chronic myeloid leukemia research? Haematologica (2013) 0.81
Monitoring after successful therapy for chronic myeloid leukemia. Hematology Am Soc Hematol Educ Program (2012) 0.78
Management of the new patient with CML in chronic phase. Curr Hematol Malig Rep (2013) 0.77
Studies in the biochemistry of micro-organisms: The metabolic products of the Penicillium brevi-compactum series. Biochem J (1932) 11.42
Confidential inquiry into quality of care before admission to intensive care. BMJ (1998) 11.32
Studies in the biochemistry of micro-organisms: The metabolic products of Penicillium Charlesii G. Smith. Biochem J (1934) 10.22
Studies in the biochemistry of micro-organisms: The metabolic products of Aspergillus terreus Thom. A new mould metabolic product-terrein. Biochem J (1935) 7.74
Studies in the biochemistry of micro-organisms: The metabolic products of Aspergillus terreus Thom. Part II. Two new chlorine-containing mould metabolic products, geodin and erdin. Biochem J (1936) 6.60
Use of warfarin in non-rheumatic atrial fibrillation: a commentary from general practice. Br J Gen Pract (1995) 6.43
Hours, volume, and type of work of preregistration house officers. BMJ (1990) 5.68
Structure of yeast phenylalanine transfer RNA at 2.5 A resolution. Proc Natl Acad Sci U S A (1975) 4.57
A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. Military Medical Consortium for Applied Retroviral Research. N Engl J Med (1991) 4.23
Childhood leukaemia in the West Berkshire and Basingstoke and North Hampshire District Health Authorities in relation to nuclear establishments in the vicinity. Br Med J (Clin Res Ed) (1987) 4.17
Studies in the biochemistry of micro-organisms: The metabolic products of Byssochlamys fulva Olliver and Smith. Biochem J (1933) 3.74
A crystallographic study of metal-binding to yeast phenylalanine transfer RNA. J Mol Biol (1977) 3.71
A hypothesis on a specific sequence-dependent conformation of DNA and its relation to the binding of the lac-repressor protein. J Mol Biol (1979) 3.62
A pooled analysis of magnetic fields and childhood leukaemia. Br J Cancer (2000) 3.49
Crystallographic refinement of yeast phenylalanine transfer RNA at 2-5A resolution. J Mol Biol (1976) 3.25
Is the normalisation of blood pressure in bleeding trauma patients harmful? Lancet (2001) 3.24
A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res (2010) 3.15
Fetal loss, gravidity, and pregnancy order. Early Hum Dev (1978) 3.06
Cardiovascular and catecholamine responses to laryngoscopy with and without tracheal intubation. Br J Anaesth (1987) 3.05
Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am J Psychiatry (1998) 3.02
Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes. J Exp Med (1987) 3.02
The specialist of the discipline of general practice. Semantics and politics mustn't impede the progress of general practice. BMJ (2000) 2.98
Plasmonic nanorod metamaterials for biosensing. Nat Mater (2009) 2.94
The awakening cortisol response: methodological issues and significance. Stress (2004) 2.88
Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J Exp Med (1988) 2.85
Further refinement of the structure of yeast tRNAPhe. J Mol Biol (1978) 2.71
Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging. Neuropsychopharmacology (1998) 2.70
Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network. Br J Cancer (2011) 2.69
Postoperative wound infection: a computer analysis. Br J Surg (1971) 2.67
PrP genotype and agent effects in scrapie: change in allelic interaction with different isolates of agent in sheep, a natural host of scrapie. J Gen Virol (1994) 2.63
Sources and types of referral to a haematology department. Health Trends (1992) 2.48
Hydrogen-poor superluminous stellar explosions. Nature (2011) 2.48
Symptoms after primary immunisation with DTP and with DT vaccine. Lancet (1984) 2.48
Can we influence medical students' approaches to learning? Med Teach (2005) 2.46
The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation. AJNR Am J Neuroradiol (1993) 2.44
Purchasing 'legal highs' on the Internet--is there consistency in what you get? QJM (2010) 2.43
Selection of an obstetric data base for a microcomputer and its use for on-line production of birth notification forms, discharge summaries and perinatal audit. Br J Obstet Gynaecol (1983) 2.36
Critical windows of exposure for children's health: cancer in human epidemiological studies and neoplasms in experimental animal models. Environ Health Perspect (2000) 2.34
Does cerebral blood flow decline in healthy aging? A PET study with partial-volume correction. J Nucl Med (2000) 2.33
A comparison of standardized and proportional mortality ratios. Stat Med (1984) 2.27
Medical progress. Diverticular disease of the colon. N Engl J Med (1980) 2.26
Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci U S A (1999) 2.25
Genetic abnormalities during transition from Helicobacter-pylori-associated gastritis to low-grade MALToma. Lancet (1995) 2.21
Spinal internuncial neurones in progressive encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry (1979) 2.20
Echocardiographic measurement of the normal adult right ventricle. Br Heart J (1986) 2.16
The RNP domain: a sequence-specific RNA-binding domain involved in processing and transport of RNA. Trends Biochem Sci (1995) 2.16
Studies in the biochemistry of micro-organisms: Fumaryl-dl-alanine (fumaromono-dl-alanide), a metabolic product of Penicillium resticulosum sp.nov. Biochem J (1942) 2.13
Should we patch corneal abrasions? A meta-analysis. J Fam Pract (1998) 2.12
Sequence analysis of the cloned streptococcal cell surface antigen I/II. FEBS Lett (1989) 2.11
Epidural anaesthesia and analgesia: better outcome after major surgery?. Growing evidence suggests so. BMJ (1999) 2.10
Reversible restoration of the birefringence of cold-treated, isolated mitotic apparatus of surf clam eggs with chick brain tubulin. Nature (1974) 2.08
Science, medicine, and the future: Pharmacogenetics. BMJ (2000) 2.06
Antidepressants and side effects. Aust N Z J Psychiatry (1995) 2.02
Early marker for Alzheimer's disease: the atrophic hippocampus. Lancet (1989) 2.02
A complex between the MHC class I homologue encoded by human cytomegalovirus and beta 2 microglobulin. Nature (1990) 2.01
Generalists in medicine. BMJ (1994) 2.01
Antibiotics and surgery for vesicoureteric reflux: a meta-analysis of randomised controlled trials. Arch Dis Child (2003) 1.99
Endoscopic management of tumors of the major duodenal papilla: Refined techniques to improve outcome and avoid complications. Gastrointest Endosc (2001) 1.99
Take action to prevent diabetes--the IMAGE toolkit for the prevention of type 2 diabetes in Europe. Horm Metab Res (2010) 1.99
Viruses causing gastroenteritis. Clin Microbiol Infect (2003) 1.99
Atomic co-ordinates for yeast phenylalanine tRNA. Nucleic Acids Res (1975) 1.98
Mechanisms of magnesium-stimulated adhesion of osteoblastic cells to commonly used orthopaedic implants. J Biomed Mater Res (2002) 1.97
Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum. Gut (2000) 1.95
Asymptomatic hypercholesterolaemia. BMJ (1991) 1.92
Alzheimer disease: measuring loss of cerebral gray matter with MR imaging. Radiology (1991) 1.92
Accuracy of burn size estimation and subsequent fluid resuscitation prior to arrival at the Yorkshire Regional Burns Unit. A three year retrospective study. Burns (1999) 1.92
Individual risk factors for hip osteoarthritis: obesity, hip injury, and physical activity. Am J Epidemiol (1998) 1.90
Oesophageal apoplexy. Lancet (1974) 1.88
CD4(+) T cell effectors can become memory cells with high efficiency and without further division. Nat Immunol (2001) 1.88
Ward design in relation to postoperative wound infection. I. Br Med J (1971) 1.85
Tobacco and the risk of acute leukaemia in adults. Br J Cancer (1999) 1.85
Light echoes reveal an unexpectedly cool η Carinae during its nineteenth-century Great Eruption. Nature (2012) 1.85
National symptom surveillance using calls to a telephone health advice service--United Kingdom, December 2001-February 2003. MMWR Morb Mortal Wkly Rep (2004) 1.82
The Global TB Drug Facility: innovative global procurement. Int J Tuberc Lung Dis (2004) 1.81
A school-based epidemiological study of dental neglect among adolescents in a deprived area of the UK. Br Dent J (2012) 1.79
Childhood leukaemia in West Berkshire. Lancet (1985) 1.76
Are the children of fathers whose jobs involve contact with many people at an increased risk of leukaemia? Occup Environ Med (1999) 1.76
The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma. Gut (2005) 1.73
Use of capillary blood in measurement of arterial PO2. Br Med J (1968) 1.73
Neurofilaments are transported rapidly but intermittently in axons: implications for slow axonal transport. J Neurosci (2000) 1.73
Studies of missed opportunities for immunization in developing and industrialized countries. Bull World Health Organ (1993) 1.71
Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease. Diabetes (2001) 1.70
MALToma-like lesions in the murine gastric mucosa after long-term infection with Helicobacter felis. A mouse model of Helicobacter pylori-induced gastric lymphoma. Am J Pathol (1995) 1.70
Genetic analysis of the human cytochrome P450 CYP2C9 locus. Pharmacogenetics (1996) 1.67
Preclinical and clinical pharmacology of Rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Am J Cardiol (2001) 1.66
Changing epidemiology and ecology of highly pathogenic avian H5N1 influenza viruses. Avian Dis (2007) 1.65
Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age. Vaccine (1999) 1.65
ABC of intensive care. Criteria for admission. BMJ (1999) 1.65
CT diagnostic features of Alzheimer disease: importance of the choroidal/hippocampal fissure complex. AJNR Am J Neuroradiol (1990) 1.62
Repeatability and validity of an upper limb and neck discomfort questionnaire: the utility of the standardized Nordic questionnaire. Occup Med (Lond) (1999) 1.62
The pill, parity, and rheumatoid arthritis. Arthritis Rheum (1990) 1.62
Raised mortality from lung cancer and high sex ratios of births associated with industrial pollution. Br J Ind Med (1985) 1.62
CYT387, a selective JAK1/JAK2 inhibitor: in vitro assessment of kinase selectivity and preclinical studies using cell lines and primary cells from polycythemia vera patients. Leukemia (2009) 1.61
Validation of the premature infant pain profile in the clinical setting. Clin J Pain (1999) 1.61
Low birthweight and preterm delivery, Scotland, 1981-84: effect of parents' occupation. Lancet (1991) 1.61
Physicians' knowledge of cost: the case of diagnostic tests. Inquiry (1976) 1.60